Sunesis Pharmaceuticals

www.sunesis.com

Sunesis Pharmaceuticals Reviews

4 Reviews
4.3
4 Reviews

Recommend to a friend
Approve of CEO
Sunesis Pharmaceuticals President, CEO, and Director Dan Swisher Jr.
Dan Swisher Jr.
3 Ratings
  •  

    I had a great experience at Sunesis. Was able to contribute and was recognized for it.

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee

    I worked at Sunesis Pharmaceuticals

    Pros

    Professionalism. Team spirit. Excellent benefits. Sunesis is working on a product that will make a difference.

    Cons

    Some training and development should be offered.

    Advice to ManagementAdvice

    Continue recognizing those who go above and beyond for the team.

    Recommends
    Neutral Outlook
    Approves of CEO

Sunesis Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.sunesis.com
Headquarters South San Francisco, CA
Size 16 to 50 Employees
Founded Unknown
Type Company - Public (SNSS)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

Sunesis builds drugs in miniature first before it builds them in full scale. The biotech firm's method involves building small drug fragments and then examining their protein-binding ability and potential for development. Once a fragment shows potential, Sunesis then builds a larger therapeutic compound based upon its model. Its drug candidates target various forms of cancer. Its lead candidate SNS-595 is in clinical trials to evaluate its effect on ovarian cancer and acute myeloid leukemia. Its other candidates include SNS-314, which is being studied for its effect on... More

Work at Sunesis Pharmaceuticals? Share Your Experiences

Sunesis Pharmaceuticals

 
Click to Rate
or